Anna Lorenzen

793 total citations
26 papers, 659 citations indexed

About

Anna Lorenzen is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna Lorenzen has authored 26 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 15 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna Lorenzen's work include Adenosine and Purinergic Signaling (18 papers), Receptor Mechanisms and Signaling (12 papers) and Neuropeptides and Animal Physiology (5 papers). Anna Lorenzen is often cited by papers focused on Adenosine and Purinergic Signaling (18 papers), Receptor Mechanisms and Signaling (12 papers) and Neuropeptides and Animal Physiology (5 papers). Anna Lorenzen collaborates with scholars based in Germany, Netherlands and Italy. Anna Lorenzen's co-authors include Ulrich Schwabe, Adriaan P. IJzerman, Ivars Kalvinsh, V. G. Andrianov, Karl‐Norbert Klotz, Miriam de Groote, U Gebhardt, Monika Warmuth‐Metz, Jale Özyurt and Erica W. van Tilburg and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and British Journal of Pharmacology.

In The Last Decade

Anna Lorenzen

26 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lorenzen Germany 15 336 305 143 114 91 26 659
Minta Huang Canada 14 494 1.5× 188 0.6× 333 2.3× 28 0.2× 38 0.4× 16 779
Jessie Zhang United States 12 499 1.5× 84 0.3× 109 0.8× 128 1.1× 21 0.2× 15 881
Abesh Kumar Bhattacharjee United States 17 288 0.9× 55 0.2× 155 1.1× 15 0.1× 23 0.3× 29 806
Victoria Moncada United States 13 305 0.9× 26 0.1× 269 1.9× 43 0.4× 76 0.8× 15 594
Brock Brown United States 12 254 0.8× 40 0.1× 83 0.6× 138 1.2× 155 1.7× 19 720
Sílvia Sánchez Spain 18 227 0.7× 74 0.2× 126 0.9× 23 0.2× 8 0.1× 53 638
W J Parsons United States 10 375 1.1× 96 0.3× 79 0.6× 30 0.3× 10 0.1× 11 646
Lauren J. Murphree United States 9 237 0.7× 217 0.7× 160 1.1× 90 0.8× 8 0.1× 11 554
Cristina Zocchi Italy 14 509 1.5× 626 2.1× 166 1.2× 220 1.9× 109 1.2× 26 902
Bichoy H. Gabra Canada 20 421 1.3× 68 0.2× 521 3.6× 44 0.4× 23 0.3× 34 983

Countries citing papers authored by Anna Lorenzen

Since Specialization
Citations

This map shows the geographic impact of Anna Lorenzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lorenzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lorenzen more than expected).

Fields of papers citing papers by Anna Lorenzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lorenzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lorenzen. The network helps show where Anna Lorenzen may publish in the future.

Co-authorship network of co-authors of Anna Lorenzen

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lorenzen. A scholar is included among the top collaborators of Anna Lorenzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lorenzen. Anna Lorenzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özyurt, Jale, Anna Lorenzen, U Gebhardt, et al.. (2014). Remote effects of hypothalamic lesions in the prefrontal cortex of craniopharygioma patients. Neurobiology of Learning and Memory. 111. 71–80. 26 indexed citations
2.
Özyurt, Jale, Christiane M. Thiel, Anna Lorenzen, et al.. (2014). Neuropsychological Outcome in Patients with Childhood Craniopharyngioma and Hypothalamic Involvement. The Journal of Pediatrics. 164(4). 876–881.e4. 54 indexed citations
3.
Rivkees, Scott A., et al.. (2005). A “locked-on,” constitutively active mutant of the adenosine A1 receptor. European Journal of Pharmacology. 510(1-2). 1–8. 21 indexed citations
4.
Klaasse, Elisabeth, Sophie Roerink, Anna Lorenzen, et al.. (2004). Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi α-subunits. European Journal of Pharmacology. 499(1-2). 91–98. 4 indexed citations
5.
Künzel, Jacobien K. von Frijtag Drabbe, et al.. (2003). Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues. Bioorganic & Medicinal Chemistry. 12(1). 139–149. 21 indexed citations
6.
Lorenzen, Anna, et al.. (2002). G protein-coupled receptor for nicotinic acid in mouse macrophages. Biochemical Pharmacology. 64(4). 645–648. 28 indexed citations
7.
Lorenzen, Anna, Margot W. Beukers, Jacqueline E. van Muijlwijk‐Koezen, et al.. (2002). Modulation of agonist responses at the A1 adenosine receptor by an irreversible antagonist, receptor–G protein uncoupling and by the G protein activation state. Biochemical Pharmacology. 64(8). 1251–1265. 14 indexed citations
8.
Volpini, Rosaria, Stefano Costanzi, Catia Lambertucci, et al.. (2001). Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A 3 adenosine receptor. Bioorganic & Medicinal Chemistry Letters. 11(14). 1931–1934. 45 indexed citations
9.
Lorenzen, Anna, et al.. (2001). Characterization of a G Protein-Coupled Receptor for Nicotinic Acid. Molecular Pharmacology. 59(2). 349–357. 95 indexed citations
10.
Tilburg, Erica W. van, et al.. (1999). N6,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A3 Receptor. Journal of Medicinal Chemistry. 42(8). 1393–1400. 37 indexed citations
11.
12.
Vittori, Sauro, Anna Lorenzen, Stefano Costanzi, et al.. (1999). N-Cycloalkyl Derivatives of Adenosine and 1-Deazaadenosine as Agonists and Partial Agonists of the A1 Adenosine Receptor. Journal of Medicinal Chemistry. 43(2). 250–260. 36 indexed citations
13.
Lorenzen, Anna, et al.. (1998). Heterogeneous forms of adenotin-1 of different subcellular localization. Biochemical Pharmacology. 55(4). 455–464. 2 indexed citations
14.
Lorenzen, Anna, et al.. (1998). Activation of various subtypes of G-protein α subunits by partial agonists of the adenosine A1 receptor. Biochemical Pharmacology. 56(10). 1287–1293. 23 indexed citations
15.
Lorenzen, Anna, et al.. (1997). Biological activities of N6,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A1 receptors. European Journal of Pharmacology. 334(2-3). 299–307. 14 indexed citations
16.
Lorenzen, Anna, et al.. (1996). Characterization of a novel adenosine binding protein sensitive to cyclic AMP in rat brain cytosolic and particulate fractions. Biochemical Pharmacology. 52(9). 1375–1385. 9 indexed citations
17.
Lorenzen, Anna, et al.. (1993). Affinity of central adenosine A1 receptors is decreased in spontaneously hypertensive rats. European Journal of Pharmacology Molecular Pharmacology. 244(3). 223–230. 24 indexed citations
18.
19.
Nölte, D., et al.. (1992). Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(2). 234–237. 38 indexed citations
20.
Lorenzen, Anna, et al.. (1992). Identification of a novel high affinity adenosine binding protein from bovine striatum. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(1). 63–68. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minta Huang Breakdown of academic impact, for papers by Jessie Zhang Breakdown of academic impact, for papers by Abesh Kumar Bhattacharjee Breakdown of academic impact, for papers by Victoria Moncada Breakdown of academic impact, for papers by Brock Brown Breakdown of academic impact, for papers by Sílvia Sánchez Breakdown of academic impact, for papers by W J Parsons Breakdown of academic impact, for papers by Lauren J. Murphree Breakdown of academic impact, for papers by Cristina Zocchi Breakdown of academic impact, for papers by Bichoy H. Gabra
Rankless by CCL
2026